| Due Diligence for Asset Managers |
|---|
|
You have viewed 8 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Nantkwest Inc | |
|---|---|
| Ticker | IBRX |
| CIK # | 0001326110 |
| CUSIP | 45256X103 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 3530 John Hopkins Court, San Diego, CA 92121 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Immunitybio Inc | 2023-09-22 | 470.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $1,000,000 · Revenue: Decline to Disclose |
| Nantkwest Inc | 2015-08-05 | 17.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Conkwest Inc | 2015-01-05 | 47.5 M | Exemption: 506(b) · Duration: One year or less · Revenue: $1 - $1,000,000 |
| Zellerx Corp | 2009-10-09 | 0.4 M | Exemption: 506 · Minimum: $5,000 · Remaining: $74,300 · Duration: One year or less · Commission: $26,713 · Revenue: No Revenues |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001326110] | 10-K | |
| [0001326110] | 10-Q | |
| [0001326110] | 3 | |
| [0001326110] | 4 | |
| [0001326110] | 5 | |
| [0001326110] | 8-K | |
| [0001326110] | D | |
| [0001326110] | SC 13D | |
| [0001326110] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Simon Barry J | Nantkwest Inc | [2018-02-13] | 5.9 |
| Sorrento Therapeutics Inc | Nantkwest Inc | [2016-02-17] | 6.92 |
| Bonderman Family Limited Partnership | Nantkwest Inc | [2016-02-12] | 5.5 |
| Cambridge Equities LP | Nantkwest Inc | [2015-08-31] | 51.8 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Simon Barry J
Common Stock
|
2026-02-24 | Sell | 75,000 | $12.01 | 900,750 |
|
Selecky Christobel
Common Stock
|
2026-02-23 | Sell | 25,000 | $10.00 | 250,000 |
|
Selecky Christobel
Common Stock
|
2026-02-23 | Option exercise | 25,000 | $2.98 | 74,500 |
|
Simon Barry J
Common Stock
|
2026-02-23 | Sell | 165,000 | $10.25 | 1,691,250 |
|
Selecky Christobel
Stock Option (right to buy) · derivative
|
2026-02-23 | Option exercise | 25,000 | $0.00 | |
|
California Capital Equity LLC +4
Common Stock
|
2026-02-22 | Tax withheld | 58,170 | $8.70 | 506,079 |
|
Adcock Richard
Common Stock
|
2026-02-22 | Option exercise | 152,439 | $0.00 | |
|
Sachs David C
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 40,650 | $0.00 | |
|
Simon Barry J
Common Stock
|
2026-02-22 | Tax withheld | 6,026 | $8.70 | 52,426 |
|
California Capital Equity LLC +4
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
Simon Barry J
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 15,243 | $0.00 | |
|
Sachs David C
Common Stock
|
2026-02-22 | Option exercise | 40,650 | $0.00 | |
|
California Capital Equity LLC +4
Common Stock
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
Sachs David C
Common Stock
|
2026-02-22 | Tax withheld | 20,682 | $8.70 | 179,933 |
|
Adcock Richard
Common Stock
|
2026-02-22 | Tax withheld | 77,560 | $8.70 | 674,772 |
|
Lauer Regan J
Common Stock
|
2026-02-22 | Option exercise | 4,065 | $0.00 | |
|
Lauer Regan J
Common Stock
|
2026-02-22 | Tax withheld | 1,673 | $8.70 | 14,555 |
|
Adcock Richard
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 152,439 | $0.00 | |
|
Simon Barry J
Common Stock
|
2026-02-22 | Option exercise | 15,243 | $0.00 | |
|
Lauer Regan J
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 4,065 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 395 | 199,426,165 |
| 2025-12-31 | 277 | 174,083,703 |
| 2025-09-30 | 263 | 150,186,974 |
| 2025-06-30 | 242 | 130,775,350 |
| 2025-03-31 | 215 | 83,204,435 |
| 2024-12-31 | 205 | 85,954,792 |
| 2024-09-30 | 184 | 72,834,212 |
| 2024-06-30 | 197 | 68,540,598 |
| 2024-03-31 | 172 | 74,596,622 |
| 2023-12-31 | 151 | 60,876,174 |
| 2023-09-30 | 136 | 52,023,564 |
| 2023-06-30 | 121 | 41,701,253 |